# Exhibit Review — Gemini 3 Flash (Round 1)

**Role:** Visual exhibit advisor
**Model:** gemini-3-flash-preview (ai_studio)
**Paper:** paper.pdf
**Timestamp:** 2026-02-17T17:10:23.031128
**Route:** Direct Google API + PDF
**Tokens:** 18917 in / 1875 out
**Response SHA256:** f3c881a8730f5a4d

---

This review evaluates the visual exhibits of the paper "Paying More, Getting Less? The Perverse Effects of Medicaid HCBS Reimbursement Rate Increases on Provider Supply" according to the standards of top-tier economics journals (AER, QJE, etc.).

# Exhibit-by-Exhibit Review

## Main Text Exhibits

### Table 1: "Summary Statistics: Pre-ARPA Baseline Period (January 2018–March 2021)"
**Page:** 11
- **Formatting:** Generally professional, but the "Never-Treated" column header is cut off. Number alignment is good (right-aligned).
- **Clarity:** The comparison between Treated/Never-Treated is clear. However, the empty "Avg. payment/claim" cells for All States/Treated/Never-Treated (where values should be) suggest a rendering error.
- **Storytelling:** Essential for establishing baseline balance. 
- **Labeling:** Units are missing for "Total paid" and "Avg. payment/claim" (should specify USD). The note is comprehensive.
- **Recommendation:** **REVISE**
  - Fix the "Never-Treated" header.
  - Add "$" symbols or specify "(USD)" in row labels.
  - Ensure all mean/SD values are populated (check for data truncation).

### Table 2: "Effect of HCBS Rate Increases on Provider Outcomes"
**Page:** 14
- **Formatting:** Standard AER style. Decimal alignment is excellent.
- **Clarity:** Clean layout. 10-second parse: coefficients are negative but insignificant.
- **Storytelling:** This is the "money" table. It presents the core TWFE results across all outcomes.
- **Labeling:** Column (1)-(4) labels are clear. Significance stars are absent because results are null, but a note stating "no estimates reach significance" would be helpful for clarity.
- **Recommendation:** **KEEP AS-IS**

### Table 3: "Callaway-Sant’Anna Staggered DiD Estimates"
**Page:** 14
- **Formatting:** Professional. Good use of panels (Top: CS-DiD, Bottom: TWFE).
- **Clarity:** Comparing the robust estimator to the biased TWFE in one table is excellent storytelling.
- **Storytelling:** Crucial for addressing recent econometric critiques of TWFE.
- **Labeling:** Clear.
- **Recommendation:** **KEEP AS-IS**

### Figure 1: "Event Study: Provider Participation After Rate Increase"
**Page:** 16
- **Formatting:** High quality. Clean background, legible font.
- **Clarity:** Very high. The vertical dashed line at $t=0$ and the horizontal line at $y=0$ allow for immediate interpretation of pre-trends and post-effects.
- **Storytelling:** This is the most important figure in the paper. It proves the parallel trends assumption.
- **Labeling:** Y-axis label "ATT (Log Provider Count)" is precise.
- **Recommendation:** **KEEP AS-IS**

### Figure 2: "Event Study: Beneficiaries Served After Rate Increase"
**Page:** 17
- **Formatting:** Consistent with Figure 1.
- **Clarity:** Clear, though the wide CIs in the later periods are visually "noisy."
- **Storytelling:** Redundant with Figure 1 if the message is identical. In top journals, editors often prefer these to be panels of a single figure.
- **Labeling:** Clear.
- **Recommendation:** **REVISE**
  - **Consolidate:** Merge Figure 1 and Figure 2 into a single Figure 1 with Panel A (Providers) and Panel B (Beneficiaries). This saves space and emphasizes the consistency of the null across margins.

### Figure 3: "Personal Care Provider Counts: Treated vs. Never-Treated States"
**Page:** 18
- **Formatting:** Good, but the blue/orange lines are a bit "default ggplot."
- **Clarity:** The "ARPA Enacted" vertical line is helpful. However, raw data plots are often "spiky"; a smoothed version (or 3-month moving average) might look more professional.
- **Storytelling:** Good for transparency, showing the raw variation.
- **Labeling:** Clear.
- **Recommendation:** **MOVE TO APPENDIX**
  - The Event Study (Fig 1) is the causal evidence. The raw means are supporting evidence but distract from the causal story in the main text.

### Table 4: "Robustness Checks"
**Page:** 19
- **Formatting:** Efficient use of space with multiple panels.
- **Clarity:** Allows the reader to see that the result is robust to various subsamples and estimators in one glance.
- **Storytelling:** Vital for "bulletproofing" the paper.
- **Labeling:** Clear notes.
- **Recommendation:** **KEEP AS-IS**

### Figure 4: "Heterogeneous Effects by Provider Type"
**Page:** 20
- **Formatting:** Clean coefficient plot.
- **Clarity:** Excellent. The point estimate for "Individual" clearly shows it's the only significant negative.
- **Storytelling:** Explains *why* the total effect is negative/null (consolidation).
- **Labeling:** Good.
- **Recommendation:** **KEEP AS-IS**

### Figure 5: "Randomization Inference: Provider Count Effect"
**Page:** 22
- **Formatting:** Professional histogram. 
- **Clarity:** The "Observed" line vs. the distribution is the standard way to show RI.
- **Storytelling:** Important given the p=0.024 result vs the asymptotic p-values.
- **Labeling:** Clear.
- **Recommendation:** **KEEP AS-IS**

### Figure 6: "Dose-Response: Rate Increase Size and Provider Supply"
**Page:** 23
- **Formatting:** Simple scatter with OLS fit.
- **Clarity:** Clear, but the x-axis is heavily skewed by the Wyoming outlier (even if excluded from the fit, it stretches the axis).
- **Storytelling:** Weakest of the main figures. The paper already has Table 4 Panel E for this.
- **Labeling:** Clear.
- **Recommendation:** **MOVE TO APPENDIX**
  - The main text is currently "figure-heavy" for a null result. One event study and one heterogeneity plot are sufficient for the main narrative.

---

## Appendix Exhibits

### Table 5: "Detected HCBS Rate Increases by State"
**Page:** 32
- **Formatting:** Simple list. 
- **Clarity:** Very helpful for transparency on how the "treatment" was defined.
- **Storytelling:** Necessary for a data-driven identification strategy.
- **Labeling:** Clear.
- **Recommendation:** **KEEP AS-IS**

### Table 6: "Sun-Abraham Interaction-Weighted Estimates: Log Providers"
**Page:** 32
- **Formatting:** Professional.
- **Clarity:** Good as a numerical backup to the event study figures.
- **Storytelling:** Redundant with the figures but standard for an appendix.
- **Labeling:** Clear.
- **Recommendation:** **KEEP AS-IS**

---

# Overall Assessment

- **Exhibit count:** 4 main tables, 6 main figures, 2 appendix tables, 0 appendix figures.
- **General quality:** High. The exhibits follow the "Modern DiD" playbook (CS-DiD, Event Studies, RI, Dose-Response) which is essential for top journals today. 
- **Strongest exhibits:** Figure 1 (Event Study) and Table 3 (Estimator Comparison).
- **Weakest exhibits:** Figure 3 (Raw data spikes) and Figure 6 (redundant scatter).
- **Missing exhibits:** A **Map Figure** showing which states are "Treated" vs "Never-Treated" would be a standard and highly effective visual for a state-level DiD paper.

### Top 3 Improvements:
1.  **Consolidate Figures 1 and 2:** Create a two-panel Figure 1. This is the standard "AER look."
2.  **Add a Treatment Map:** A shaded US map showing the timing or magnitude of rate increases would immediately orient the reader to the geographic variation.
3.  **Streamline Main Text Figures:** Move Figure 3 and Figure 6 to the appendix. In top journals, every main-text figure must be "essential." The raw means and dose-response scatter are "supporting."